Patents expiring in 2031

US 7998987

Inhibitors of c-Met and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7999007

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

United Therapeutics Corporation · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7999074

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7999079

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7999077

IRTA2 antibodies and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7999113

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003660

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003112

Meningococcal and pneumococcal conjugate vaccine and method of using same

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003091

Pharmaceutical compositions comprising purified intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003103

High affinity human antibodies to human IL-18 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8001922

Application of a coating on a medical device

ATRIUM MEDICAL CORPORATION · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003406

Methods for detecting attention-deficit/hyperactivity disorder

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003685

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003619

Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003785

Halo-substituted pyrimidodiazepines

Takeda Pharmaceutical Company Limited · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003755

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003742

Polymer derivatives with proximal reactive groups

Nektar Therapeutics · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003126

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003693

Modulation of anxiety through blockade of anandamide hydrolysis

The Regents of the University of California · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003754

Paralytic peptide for use as a insecticide

Soricimed Biopharma Inc. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003692

Methods and compositions to inhibit edema factor and adenylyl cyclase

The Board of Regents of the University of Texas System · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003764

Folliculin-specific antibodies and methods of detection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003664

Indazole-carboxamide compounds

Theravance, Inc. · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003622

Peptide biosynthesis and pain therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8003629

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2011206613

METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT

WIEHE ARNO [DE] · Granted Thu Aug 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008278

Diarylmethyl and related compounds

Theravance, Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008308

Phosphonate compounds

The Regents of the University of California · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8007804

Complement receptor 2 targeted complement modulators

The Regents of the University of Colorado · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8007774

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

REGENTIS BIOMATERIALS LTD. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8007778

Use of calcium binding proteins to improve cardiac contractile function

The Regents of the University of California · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8007787

Human cystathionine β-synthase variants and methods of production thereof

The Regents of the University of Colorado · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008353

Methods for modulating macrophage proliferation using polyamine analogs

The Regents of the University of California · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008435

Polymer stabilized neuropeptides

Nektar Therapeutics · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008501

Quinoline compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008332

Substituted indazoles as glucokinase activators

Takeda San Diego, Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008266

Methods of treating cancer using immunostimulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008323

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008525

Receptor function regulating agent

Takeda Pharmaceutical Company Limited · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008510

Metalloprotein inhibitors

The Regents of the University of California · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8007853

Vitamin/mineral composition with DHA

Xanodyne Pharmaceuticals, Inc. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008316

Azonafide derived tumor and cancer targeting compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008021

N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease

Evanston Northwestern Healthcare · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8008038

Methods for determining oxygen concentration with protoporphyrin IX

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8012976

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8013015

Small molecule inhibitors of ghrelin O-acyltransferase

The Board of Regents of the University of Texas System · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8012965

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8012490

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)